Postdoctoral Research Fellow / Clinical Academic Pharmacist
Back to team

Dr Joshua Bennetts

PhD, BPharm (Hons), CredPharm

Joshua is a clinical academic pharmacist and early-career researcher at the Newcastle Centre of Excellence in Cardio-Oncology. He received his pharmacy degree from the University of Newcastle in 2018 with First Class Honours, was awarded the University’s Vice-Chancellor’s Academic Career Preparation Scholarship, and completed his PhD in Pharmacy in 2026.

As a pharmacist, Joshua’s research focuses on improving the safe and effective use of medicines for people with cardiovascular disease. This includes developing new services that give more people access to pharmacist support to prevent medication-related problems, especially as they move between hospital and home. His goal is to improve access to cardiovascular care that involves the whole healthcare team, from doctors to pharmacists, nurses and allied health, for all Australians.

Joshua has produced over 10 peer-reviewed publications and abstracts and has presented at national and international conferences. He is a credentialled pharmacist and continues to work clinically, providing Home Medicine Review services for his community.

Professional roles

  • Australian Governor, International Society of Cardiovascular Pharmacotherapy
  • Member, International Cardio-Oncology Society pharmacy working group
  • Member, Cardiac Society of Australia and New Zealand pharmacy working group

Research interests

  • Clinical pharmacy and pharmacology
  • Heart failure
  • Cardio-oncology
  • Clinical trials
  • Qualitative research
  • Models of care

Current projects

  • IMPACT-CVD in CANCER trial: dedicated cardio-oncology services for the prevention, monitoring and treatment of cardiovascular disease in patients living with, through and beyond cancer
  • SOCRATES trial: statins and the progression of coronary atherosclerosis in melanoma patients treated with checkpoint inhibitors
  • HOPES trial: Hypertension Optimised by Pharmagenic Enrichment Scoring
  • A qualitative study of cancer survivors’ experiences and perspectives on post-treatment cardiovascular care
  • The role of primary care teams in managing cardiovascular risk factors for cancer survivors
  • Risk factors for cardiovascular hospital admissions and mortality in cancer patients treated with immune checkpoint inhibitors
  • Risk factors for major adverse cardiovascular events in cancer patients treated with 5-fluorouracil

Chen DH, Butel-Simoes L, Bower M, Nolan MT, Kumar SS, Williams TD, Koczwara B, Ell P, Bennetts JD , Nair GR, Lee J. The Current Cardio-Oncology Landscape Across Australia. Current Treatment Options in Oncology. 2026 Dec;27(1):22.

Bennetts JD , Mahmud A, Yu J, Ngo DT, Sverdlov AL. From Signal to Care: Artificial Intelligence in Cardio-Oncology. Trends in cardiovascular medicine. 2026 Mar 25:S 1050-1738.

Bennetts JD , Robson C, Weismantel-Savage A, Mani J, Yu J, Robson L, Collins NJ, Williams TD, Sverdlov AL, Ngo DT. Evaluation of a Nurse-Pharmacist Post-Discharge Telehealth Model of Care for People With Heart Failure. Heart, Lung and Circulation. 2026 Mar 20.

Bennetts JD , Sverdlov AL, Ngo DT. Cardiometabolic Perturbations Arising from Treatment with Novel Anticancer Therapies. Trends in Cardiovascular Medicine. 2025 Oct 25.

Butel-Simoes LE, Albayati A, Yu J, Quirk T, Sritharan S, French M, Bennetts JD , Ngo DT, Sverdlov AL. Tyrosine kinase inhibitors-balancing the haemostatic scales: a review of associated thrombosis and bleeding. Journal of Thrombosis and Thrombolysis. 2025 Sep 15:1-8.

Bennetts J , Robson C, Weismantel-Savage A, Mani J, Yu J, Robson L, Collins N, Williams T, Sverdlov A, Ngo D. Impact of a Nurse-Pharmacist Telehealth Model of Care on Hospital Readmissions and Prescribing of Guideline-Directed Medical Therapy for People With Heart Failure. Heart, Lung and Circulation. 2025 Aug 1; 34:S 308-9.

Bennetts JD , Williams TD, Beavers CJ, Moore HN, Robson C, Warner T, Dent S, Sverdlov AL, Ngo DT. The cardio-oncology multidisciplinary team: beyond the basics. Cardio-oncology. 2025 Jul 26;11(1):69.

Bennetts J , Robson C, Weismantel-Savage A, Mani J, Williams T, Sverdlov A, Ngo D. Feasibility and Acceptability of a Nurse-Pharmacist Post-Discharge Telehealth Model of Care for Heart Failure Patients. Circulation. 2024 Nov 12;150(Suppl_1 ):A 4126893-.

Bennetts J , Walker R, Williams T, Sverdlov A, Ngo D. Risk Factors Associated with Cardiac Hospital Admissions in Cancer Patients Treated with Immune Checkpoint Inhibitors. Circulation. 2024 Nov 12;150(Suppl_1 ):A 4117414-.

Bennetts J , Williams T, Walker R, Ngo D, Sverdlov A. Factors Associated With Cardiac Hospital Admissions in Cancer Patients Treated With Immune Checkpoint Inhibitors. Heart, Lung and Circulation. 2024 Aug 1; 33:S 299-300.

Bennetts J , White J, Croft H, Cooper J, McIvor D, Eadie N, Appay M, Sverdlov AL, Ngo D. Pharmacist-led medication management services: a qualitative exploration of transition-of-care cardiovascular disease patient experiences. BMJ open. 2024 May 1;14(5 ):e 082228.

Williams T, Bennetts J , Robson L, Robson C, Sverdlov A, Ngo D. The Implementation of a Virtual Pharmacy/Nurse Post-Discharge Model of Care: A Pilot Study. Heart, Lung and Circulation. 2023 Jul 1; 32:S 333.